The Direct-to-Patient Channel in Pharma: A Practical Guide to Protect GTN, Expand Access, and Improve Patient Experience
On July 31, 2025, the White House escalated U.S. drug pricing pressure by sending letters to 17 pharmaceutical CEOs demanding concrete steps to align U.S. prices with “most favored nation” (MFN) levels. At the same time, affordability pressure is rising from the bottom up. Patient out-of-pocket spending reached $98 billion in 2024, up nearly 25% […]